机译:Emerging HER2-directed therapeutic agents for gastric cancer in early phase clinical trials
Dept Med,Royal Marsden Hosp;
Antibody-drug conjugate (ADC); gastric cancer; HER2; immune stimulating antibody conjugates (ISAC); immunotherapy; trastuzumab; trastuzumab deruxtecan; OPEN-LABEL; GASTROESOPHAGEAL JUNCTION; TRASTUZUMAB EMTANSINE; HER2 INHIBITION; ADENOCARCINOMA; AMPLIFICATION; BREAST; ERBB2; CHEMOTHERAPY; COMBINATION;